Replies to post #339127 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

Nasrat on Adderall XR:

- “This is an outstanding product for us once we get an approval because we will be the fifth in this arena, and even if there were more people than that and we've got just 10% of that market, that's $160 million, a $160 million in revenues will do wonders to Elite stock. Even if we cut it in half between us and SunGen and you take out the actual cost which is another half and walk away with only $40 million, that will take our market cap from 80 million which is today to $800 million with one product only."

NASRAT: Adderall XR is a 10-bagger for Elite's stock.

REALITY: Adderall XR made Elite's stock DROP.................let alone even hold steady.

where did he “promise” we would get $80 mil? doesn’t seem likely that he would “promise” a particular amount of revenue. Too much not under his control.